Related by context. All words. (Click for frequent words.) 76 QNEXA ® 75 davalintide 74 Empatic TM 72 MKC# 72 MKC# MT 71 Empatic ™ 69 Syncria albiglutide 69 approved incretin mimetic 69 albiglutide currently 69 trodusquemine MSI 68 pramlintide metreleptin 68 Testosterone MDTS R 68 Inc. Nasdaq OREX 67 products MKC# PP 67 avanafil PDE5 inhibitor 67 diabetes hyperlipidemia 67 MKC# MKC# PP 67 LymphoStat B belimumab 67 QNEXA 67 serine protease inhibitor CU# 67 recombinant PSMA vaccine 66 Luramist TM 66 Bayer HealthCare Onyx Pharmaceuticals 66 Testosterone MDTS ® 66 delta gamma agonist 66 diabetes dyslipidemia 66 albiglutide 65 Crofelemer budesonide foam 65 BLOOM Behavioral modification 65 systemic Phase 1b 65 cancer indications bafetinib 65 Inc. NASDAQ OREX 65 lintuzumab SGN 65 gastrin analogue TT 65 non cirrhotic portal 65 initiate multicenter 65 ALN VSP Phase 65 REVIVE TA 64 targeting miR 64 rheumatoid arthritis inflammatory bowel 64 deCODE AF TM 64 Tramiprosate ALZHEMED TM 64 compound INCB# 64 atherosclerosis rheumatoid arthritis 64 pralatrexate injection folate analogue 64 CDAD Clostridium difficile 64 including eniluracil ADH 64 avanafil potentially 64 tramiprosate Alzhemed TM 64 HCV NS5B polymerase 64 Tesofensine 64 pharmacogenomic translational research 64 hypertension hypercholesterolemia 64 TELINTRA R 64 phase III isavuconazole 64 degeneration gastrointestinal disorders 63 cosmetic cosmeceutical products 63 solid tumors ZYBRESTAT 63 oncolytic virus therapies 63 Pramlintide 63 Meridia sibutramine 63 EMPOWER ™ 63 Acetavance TM intravenous acetaminophen 63 Prodarsan R 63 MAGE A3 ASCI 63 GVAX R 63 CYT# potent vascular disrupting 63 thetreatment 63 HepeX B TM 63 ALN HPN 63 inflammatory autoimmune diseases 63 Budesonide foam crofelemer 63 include Alferon N 63 class PDE5 inhibitor 63 TBC# 63 trauma malignant tumors 62 Ostabolin C TM 62 humanized therapeutic 62 toenail onychomycosis 62 midstage clinical 62 vaccine GMK 62 myasthenia gravis Huntington 62 rheumatoid arthritis thrombocytopenia 62 cetilistat 62 apricitabine ATC 62 childbearing age mirrors 62 vaginally administered lidocaine 62 nasal calcitonin product 62 CG# oncolytic virus 62 includes TOLAMBA TM 62 Initiate Phase 62 non nucleoside inhibitor 62 PORxin TM platforms 62 Completes Patient Enrollment 62 clinical trials Archexin 62 Shigatoxin producing E. coli 62 GVAX ® 62 Panzem R 62 gastrointestinal stromal 62 Second Pivotal Phase 62 evaluating mipomersen 62 XP# XP# 62 acyclovir Lauriad R 62 damage cirrhosis liver 62 kidney urologic 62 DIRECT Trial 62 PYY #-# 62 EOquin TM phase 62 CNS Disorders 62 Oral Calcitonin 62 novel VDA molecule 62 CEL SCI Phase III 62 selective phosphodiesterase 62 asthma rheumatoid arthritis 62 Phase 1b clinical trials 62 VEGFR2 inhibitor 62 sapacitabine CYC# 61 XL# anticancer compounds 61 endocrinology orthopedics kidney 61 delta opioid receptor 61 granted Ortec 61 Phase lll 61 Proellex TM 61 menopause contraception 61 Diamyd ® 61 APEX PD 61 Archexin 61 multicenter Phase III 61 OAB overactive bladder 61 phase IIb study 61 Achieves Primary Endpoint 61 Tarvacin Anti Cancer 61 Taranabant 61 ThermoDox ® clinical 61 Artificial pancreas 61 HEPLISAV TM hepatitis B 61 INSPIRE Trial Phase III 61 REGN# 61 DGAT1 inhibitors 61 delivery polymer matrix 61 5 lipoxygenase inhibitor 61 oral nucleoside analogue 61 Initiates Enrollment 61 receptor inhibiting monoclonal 61 Tykerb lapatinib 61 humanized interleukin 6 61 commercialize CorMedix drug 61 TRIOLEX HE# APOPTONE HE# 61 romazarit 61 3 registrational trial 60 ChronVac C R 60 Initiated Phase 60 Oral NKTR 60 oral calcitonin licensed 60 Quinamed R 60 PLX STROKE targeting 60 Combivir Kivexa 60 JZP 60 developing Surfactant Replacement 60 evaluating T DM1 60 treatment naïve genotype 60 AAG geldanamycin analog 60 opioid induced bowel dysfunction 60 overactive bladder AA# 60 telomerase therapeutic 60 Phase #b/#a clinical 60 Amigal TM 60 Gentamicin Surgical Implant 60 Elagolix 60 evaluating Actimmune 60 LibiGel testosterone gel 60 azilsartan medoxomil 60 IMA# 60 PI3K/Akt pathway inhibitor 60 Staccato prochlorperazine 60 ragweed allergy immunotherapeutic 60 EQUATE OB 60 SinuNase ™ 60 RANK Ligand inhibitor 60 Saxagliptin 60 psoriasis Crohn disease 60 Diamyd r 60 clinical trials dacetuzumab SGN 60 number NCT# ClinicalTrials.gov 60 purified inactivated vaccine 60 oral picoplatin 60 TRACON Pharmaceuticals Inc. 60 Combination REOLYSIN R 60 rheumatoid arthritis psoriatic arthritis 60 Muraglitazar 60 FDA Approves Novel 60 HPV cervical dysplasia 60 psoriasis rheumatoid arthritis 60 deCODE ProstateCancer TM 60 virus HCV protease inhibitor 60 relapsed MM 60 Phase 2b clinical trials 60 metaglidasen 60 reslizumab 60 Luramist 60 6R BH4 60 R#/MEM # 60 mesylate tablets approved 60 IIa clinical trials 60 EMPOWER Study 60 Aflibercept 60 intravenous RSD# 60 Rigel R# 60 Initiates Phase II 60 Commences Phase 60 highly purified pasteurized 60 PrevOnco ™ 60 diarrhea predominant irritable 60 non porcine pancreatic 60 seliciclib CYC# 60 heFH 60 EVIZON TM squalamine lactate 60 LymphoStat B TM 59 Randomized Phase 59 chronic thromboembolic pulmonary 59 product platforms AZX# 59 RhuDex R 59 PF # [002] 59 catheter occlusion 59 non constipating irritable 59 Phase III Pivotal 59 PREOS R 59 DEB# 59 HYVISC ® treatment 59 drug pipeline TAFA# 59 leading oral taxane 59 next generation URAT1 59 trial evaluating PRX# 59 include ColorectAlert TM 59 treatment naive genotype 59 Amgen Neulasta R 59 ViaDerm hPTH #-# 59 Unigene nasal calcitonin 59 Amylin Takeda 59 mGluR2 positive 59 Troxatyl 59 evaluating tesamorelin 59 lorcaserin hydrochloride 59 Pimavanserin 59 lomitapide 59 SinuNase TM 59 blinded randomized placebo controlled 59 Successfully Completes Phase 59 forodesine 59 novel therapeutic antibodies 59 R sorafenib tablets 59 PSN# [002] 59 Anturol TM 59 Contrave# 59 candidate CRLX# 59 Exherin TM 59 Submits Response 59 placebo controlled Phase 59 evaluating bafetinib 59 Phase 2b Clinical Trial 59 4SC AG ISIN DE# 59 Randomized Double blind 59 Telik logo TELINTRA 59 Inotek Pharmaceuticals Corporation 59 Vertex hepatitis C 59 TRIOLEX ™ 59 Zemplar Capsules 59 inflammation thrombosis oncology 59 compound tesamorelin 59 HIV AIDS neuropathic pain 59 Phase Ib IIa 59 tesofensine 59 Orexigen Contrave 59 confirmatory Phase IIIb 59 clinical trials SGN 59 colorectal bladder 59 oral opioid modulator 59 Mg Uk 59 Boniva ibandronate 59 initiated Phase Ib 59 MOVIPREP R 59 bile duct tumor 59 drug NP2 Enkephalin 59 Zolpimist ™ 59 MEND CABG 59 recombinant biopharmaceutical 59 Cerebral Amyloid Angiopathy 59 ASONEP ™ 59 CHAMPION PCI 59 oral prodrug 59 bavituximab monotherapy trial 59 Darapladib 59 CCR5 mAb 59 pill Galvus 58 investigating Serdaxin 58 PANVAC VF 58 novel antimitotic agent 58 TNFerade TM 58 treat secondary hyperparathyroidism 58 aripiprazole Abilify 58 lexidronam injection 58 ELADUR ™ 58 HCV polymerase inhibitors 58 Genasense oblimersen sodium Injection 58 rALLy clinical trial 58 refractory gout 58 LungAlert TM 58 Phase III ADT 58 Pharmos pipeline 58 drug figitumumab 58 PYY nasal spray 58 lorcaserin Phase 58 GetGoal Phase III 58 sirtuin inhibitor program 58 GATTEX ® 58 HEPLISAV ™ 58 Matrix Phase 2b 58 RELOVAIR ™ 58 Liprotamase 58 RhuDex 58 Prodarsan 58 Hormone Refractory Prostate Cancer 58 DDP# 58 Stab stab 58 regorafenib 58 Nanobody R 58 ONCONASE R 58 pentadentate logo R 58 budesonide foam 58 Hypoactive Sexual Desire Disorder 58 skateboarding BMX Motocross 58 FOLOTYN ® 58 pivotal bioequivalence 58 RECORD1 58 sulfonylurea metformin 58 severe hypercholesterolemia 58 AOD# [002] 58 anaphylactic reactions bronchospasm 58 ospemifene 58 Diamyd R 58 CTA# Injection 58 cytomegalovirus CMV HAE 58 PMX # heptagonist 58 bone marrow reticulin deposition 58 refractory chronic lymphocytic 58 verdict elicited gasps 58 Januvia sitagliptin 58 Wyeth Progenics 58 candidate REP# 58 methylnaltrexone bromide 58 BioSante LibiGel Phase III 58 www.BYETTA.com 58 autoimmune disorders asthma 58 pramlintide 58 Pivotal Phase 58 Dapagliflozin 58 Ceflatonin R 58 Stomach pacemaker 58 Personalized Immunotherapy 58 alvespimycin 58 ALISTA TM 58 CINQUIL 58 oral PTH 58 E1 INT TM 58 trodusquemine 58 opioid bowel dysfunction 58 HCD# [002] 58 rhIGF-I/rhIGFBP-3 58 obesity insulin resistance 58 oral ridaforolimus 58 sitaxsentan sodium 58 generation URAT1 inhibitor 58 RhuDex TM 58 MSCRAMM ® 58 Inovio clinical 58 insulin resistance precursor 58 relapsing remitting MS RRMS 58 Solazed 58 benign prostatic hyperplasia enlarged 58 adecatumumab MT# 58 APF# Phase 57 oral proteasome inhibitor 57 brivanib 57 include Altastaph TM 57 Phase IIa trials 57 dimebon latrepirdine 57 Sugar sweetened beverages 57 AcryMed Incorporated 57 Daclizumab 57 Lisofylline LSF 57 BENLYSTA ™ 57 REMINYL ® 57 alpha 2A adrenergic 57 manufactures minimally invasive 57 multicenter Phase 57 oral sapacitabine 57 agonistic human 57 non nucleoside HCV 57 TransVax 57 IMPACT DCM 57 Peyronie disease Frozen Shoulder 57 multicenter dose escalation 57 Syncria 57 anti PlGF 57 transmucosal delivery system 57 pill Qnexa 57 induced macular edema 57 progressive metastatic prostate 57 Risperidone Oral Solution 57 Efficacy Results 57 CDK cyclin dependent 57 candidate Liposomal Grb 57 bevirimat Study 57 Albuferon Phase 57 Pyridorin TM 57 include GALNS N 57 budesonide MMX Phase III 57 elevated fasting glucose 57 mertansine 57 hypoxia activated prodrug 57 CAPACITY trials 57 ADVANCE PD 57 Naive Patients 57 liprotamase 57 constipation OIC 57 Inc. NASDAQ HDIX 57 lenalidomide Revlimid R 57 acetonide FA 57 oxypurinol 57 anastrozole Arimidex 57 Sudhir Agrawal D.Phil 57 LAB CGRP 57 prokinetic agent 57 randomized controlled multicenter 57 orally administered compounds 57 immunosuppressive compound 57 delay bone metastases 57 NYSE Amex NBY clinical 57 Onglyza saxagliptin 57 homozygous familial hypercholesterolemia 57 torsemide ER 57 BRIM3 57 Phase Ib II 57 cromolyn sodium 57 OvaRex ® MAb 57 REVIVE Diabetes 57 systemic juvenile idiopathic 57 PREGNANT PROCHIEVE Extending GestatioN 57 unresectable HCC 57 LibiGel ® testosterone gel 57 Brussels THR 57 metformin sulfonylurea 57 Teriflunomide 57 cardiometabolic disorders 57 investigational monoclonal antibody 57 Other ImmunoGen collaborative 57 Zenvia ™ 57 Daliresp 57 GALNS 57 ALS #-# 57 alemtuzumab Campath 57 elotuzumab 57 nalbuphine ER 57 bapineuzumab AAB 57 GEM OS2 57 Pivotal Phase III 57 proprietary radiolabeled monoclonal 57 CB2 selective receptor agonist 57 GATTEX ™ 57 IAP inhibitor 57 confirmatory pivotal 57 ASH Abstract # 57 EXPLORE Xa 57 Zemiva TM 57 LUX Lung 57 PLK1 SNALP 57 Vicriviroc 57 2 methoxyestradiol 57 EQUIP OB 57 TKB# 57 TRAIL receptor antibody 57 Ixempra 57 Evoltra ® 57 Fabry Disease 57 Fibrillex TM 57 comparing alemtuzumab 57 Urocortin 2 57 recurrent metastatic ovarian cancer 57 sorafenib tablets 57 MCSP respectively 57 TLR9 agonist IMO 57 Amgen Neulasta ® 57 torezolid phosphate 57 skeletal sarcomere activator 57 pruritus rash 57 aflibercept VEGF Trap 57 phase IIb trial 57 adrenergic regulation 57 Meets Primary Endpoint 57 Phase 2a clinical trials 57 drug Treanda 57 Canvaxin TM 57 mGluR2 NAM 57 ® bortezomib 57 SIMCOR 57 uterine fibroid induced 57 5 HT2A inverse 57 CTAP# Capsules 57 neuroscience autoimmune 57 INxin TM 57 Truvada tablets 57 XL# SAR# 57 visilizumab 57 Ophena TM 57 Advaxis Phase 57 SILENOR 57 Mipomersen 57 NuroPro R 57 AKT inhibitor 57 TRO# 57 candidates Azedra TM 57 BRIM2 57 ILUVIEN ® 57 Multiple Ascending Dose 57 AcryMed technologies 57 refractory metastatic 57 naïve HCV 57 phase IIb clinical 57 indiplon capsules 57 Ferring Pharmaceuticals privately 56 Denufosol 56 Edurant 56 Aryplase 56 GSK# [002] 56 Tesetaxel 56 Cholesterol Levels SPARCL 56 CYT# vascular disrupting 56 Phase 2b Trial 56 Serdolect ® 56 Fx #A 56 neovascular form 56 demonstrated antitumor activity 56 initiate Phase IIb 56 Phase IIb Trial 56 fusion enhancers 56 evaluating picoplatin 56 PGL# 56 nucleotide analog 56 solanezumab 56 ENTOCORT EC 56 AERx ® 56 Shows Promise Against 56 TRAIL receptor antibody mapatumumab 56 Meleanie Hain loaded 56 riociguat 56 Phase III multicenter 56 investigational protease inhibitor 56 MSCRAMM R 56 Empatic 56 IIb clinical trial 56 radiation enteritis 56 Selective Electrochemical Tumor Ablation 56 Oglemilast 56 LibiGel ® 56 angiotensin analog 56 equine osteoarthritis marketed 56 metastatic renal cell 56 INTEGRILIN R eptifibatide Injection 56 CD# CEA 56 Safinamide 56 Dose Ranging Study 56 GW# [003] 56 oral NKTR 56 pramlintide metreleptin combination 56 REG2 56 Endotoxin Activity Assay 56 LUNESTA TM 56 Phase 2a Trial 56 gets USFDA nod 56 Curaxin CBLC# 56 cSSSIs 56 sNDA submission 56 decompensated liver disease 56 RhuDex ® 56 JunJing II 56 Aceon 56 selective androgen receptor modulator 56 HCV RNA polymerase 56 BCX# 56 steroid refractory ulcerative 56 Elacytarabine 56 Phase 2a clinical 56 PRIMO CABG 56 ANCHOR trial 56 acute mania 56 CIMZIA TM certolizumab pegol 56 Zemiva ™ 56 ASCEND HF 56 AZX# Phase 56 metabolic syndrome clustering 56 Zanaflex Capsules ® tizanidine 56 Commence Phase 56 dirucotide MBP# 56 Nasdaq OPTR 56 IMC #B 56 OPT CHF 56 evaluating tivozanib 56 multicenter Phase II 56 TEMSO 56 TransVax ™ 56 headache nasopharyngitis 56 proprietary BiTE ® 56 TRANSDUR ™ 56 PDE4 inhibitor 56 Completes Enrollment 56 SUCCEED trial 56 cardiovascular disease osteoporosis 56 APPRAISE 56 Commonly prescribed 56 AstraZeneca Plc Crestor 56 investigational humanized monoclonal antibody 56 Corlux 56 cetrorelix pamoate 56 trastuzumab DM1 T DM1 56 Evamist TM 56 Ozarelix 56 Clonicel 56 eosinophilic asthma 56 malignant mesothelioma Alfacell 56 initiate Phase 2b 56 FOLFOX6 chemotherapy regimen 56 tolevamer 56 patented DepoVax TM 56 PDX pralatrexate 56 pioglitazone HCl 56 E2F Decoy 56 metastatic hormone refractory 56 BEMA Buprenorphine 56 Diabetic Macular Edema DME 56 hGH CTP Phase 56 intravenous picoplatin include 56 placebo controlled dose escalation 56 bazedoxifene conjugated estrogens 56 opioid naive 56 Prodarsan ® 56 acetylgalactosamine 6 56 metastatic colorectal 56 STRIDE PD 56 canagliflozin 56 HIV treatments Reyataz 56 include Ischemic Paraplegia 56 Parkinson disease monogenic diseases 56 XL# XL# XL# XL# 56 Vaxfectin formulated 56 steroid refractory GvHD 56 XOMA 3AB 56 COPD inhalation anthrax 56 Loramyc ™ 56 Clinical Trials Update 56 rash pruritus nausea 56 BENLYSTA ® 56 Clinical Trial Evaluating 56 Systemic Sclerosis 56 YONDELIS 56 dyskinesia PD LID 56 GLP1 INT TM 56 ARRY # 56 testing huN# DM1 56 nonalcoholic steatohepatitis 56 taranabant 56 Trial Evaluating 56 ™ testosterone gel 56 hyperphenylalaninemia HPA due 56 PSMA ADC 56 novel chimeric natriuretic 56 erlotinib Tarceva ® 56 Nipent R 56 Dose Escalation 56 antibody MAb 56 Liraglutide Effect 56 sodium thiosulfate STS 56 evaluating satraplatin 56 Teasing caresses 56 dermaceutical 56 Dyloject TM 56 Prochieve R 56 Angiotensin Therapeutic Vaccine 56 MAP Pharma 56 Astralis Ltd. 56 Atrasentan 56 cathepsin K inhibitor 56 oral rivaroxaban 56 UVIDEM 56 anticancer compound 56 Initiates Phase 56 Androxal TM 56 HuMax TAC 56 PRECISE Trial 56 Annamycin 56 metastatic castrate resistant 56 CRMD# 56 pontiff forgave 56 Dosa suffers 56 sarcoma melanoma 55 Avanafil 55 LAF# 55 PDE4 modulators 55 OncoVex 55 treat lupus renal 55 CholeraGarde R 55 Cetrorelix 55 implantable centrifugal rotary 55 basal cell carcinoma squamous 55 liposomal formulation 55 SAR# [002] 55 investigational hepatitis B 55 mGluR5 NAM 55 Brentuximab Vedotin SGN 55 Traumatic Spinal Cord Injury 55 BRAF mutant 55 colesevelam HCl 55 commercialize ZYFLO CR 55 guanfacine extended release 55 interferon gamma 1b 55 Phase IIb trials 55 ATHX 55 dependent kinase inhibitor 55 vapreotide acetate 55 Egrifta 55 inhaled AAT 55 PRX # 55 BYETTA ® 55 lipoprotein lipase deficiency LPLD 55 Triolex 55 Sapacitabine 55 commercialize deforolimus 55 CRD5 55 rumpled dresser 55 registrational Phase 55 Aurexis 55 receptor tyrosine kinase inhibitor 55 #/#/# Cytokinetics Incorporated 55 phase IIa clinical 55 debilitating complication 55 Drug Eluting Stent System 55 Shigamabs ® 55 metastatic colorectal carcinoma 55 Frova ® 55 iobenguane 55 TYGACIL 55 R DepoCyt 55 Xelox 55 IND submission 55 Study Evaluating 55 CRLX# 55 exocrine pancreatic insufficiency 55 DPP4 inhibitor 55 Allovectin 7 55 DGAT 55 CIMZIA ™ 55 fidaxomicin Phase 55 Acute myelogenous leukemia 55 PrevOnco 55 lumiliximab 55 cystic fibrosis chronic pancreatitis 55 PEGINTRON TM 55 Randomized Phase II 55 treatment Avandia Avandamet 55 lymphoma multiple myeloma 55 novel histone deacetylase 55 unique alkylating agent 55 Solazed TM 55 Myocet 55 PROGENSA R 55 Phase #/#a trial 55 phase Ib 55 Invasive pneumococcal disease 55 Tarceva TM 55 Ataluren 55 candidate Trofex TM 55 Avandia Actos 55 somatostatin analog 55 ACTEMRA TM 55 coagulation factor VIIa 55 Vandetanib 55 NATIONAL ECONOMIC COUNCIL DIRECTOR 55 Orexigen Therapeutics Inc 55 Major Depressive Disorder MDD 55 MelaFind R 55 Cannabinor 55 HIV coinfected 55 receiving chemoradiation therapy 55 treat gastrointestinal disorders 55 See BioWorld Today 55 gastrointestinal mucositis 55 FACTIVE R gemifloxacin 55 Automotive Emission Canister 55 generation rotary VAD 55 SNT MC# 55 preclinical efficacy 55 LibiGel Phase III 55 PD2i CA Cardiac Analyzer 55 Trastuzumab DM1 55 chemotherapy molecularly targeted 55 Vidaza R 55 hypertension diabetes mellitus 55 R roscovitine 55 GLP1 agonist 55 assessing T DM1 55 Traci Arbios 55 Planetwide Media My 55 SomatoKine R 55 thalidomide Thalomid 55 Perceiva 55 stable angina pectoris 55 please visit http:/www.sunesis.com 55 microsurgical disciplines 55 AEGR 55 mGluR5 negative 55 Phase IIb Clinical Trial 55 phase Ib clinical 55 Flovent HFA 55 hepatitis C HCV 55 Cloretazine ® 55 inhibit oxidative stress 55 EGS# 55 iloprost synthetic compound 55 TRAIL receptor antibodies 55 Zarnestra 55 Bayer Nexavar 55 Zolinza 55 confirmatory clinical 55 By JENNIFER LEARN 55 Spiegelmer ® 55 rheumatoid arthritis psoriasis 55 studies evaluating satraplatin 55 Amoxicillin PULSYS Phase III 55 Flutiform ™ 55 Degarelix 55 ZOLL resuscitation product 55 Heavy snorers 55 Febuxostat 55 vidofludimus 55 Paliperidone Palmitate 55 Phenoptin 55 TG MV 55 omacetaxine mepesuccinate 55 haematologic 55 LymphoStat B Phase 55 ofatumumab HuMax CD# 55 Capesaris 55 orally administered compounds TASQ 55 ZOLINZA 55 RAS MAPK pathway 55 PNT# 55 mecasermin rDNA origin 55 Phase IIIb clinical 55 nebulized budesonide 55 phase IIa 55 vildagliptin 55 hepatitis B immune globulin 55 Hsp# Inhibitor 55 Phase III PREGNANT PROCHIEVE 55 elevated creatine phosphokinase 55 myelofibrosis polycythemia vera 55 Romiplostim 55 Unit Dose Budesonide 55 taxane refractory 55 Ception Therapeutics Inc. 55 GTC recombinant human 55 PRESEPT study 55 investigational HCV polymerase 55 developing ostarine selective 55 candidates Dyloject TM 55 www.telik.com 55 PROSTASCINT R 55 followers Patricia Krenwinkle 55 BLyS specific 55 Lenocta 55 evaluating Xcytrin 55 specific CCR9 antagonist 54 Metastatic Melanoma 54 GetFugu platform 54 product Abreva ® 54 Entocort 54 brivaracetam 54 Phase IIb clinical trials 54 recurrent glioma 54 ACCLAIM COPD 54 obesity sedentary lifestyle 54 oral methylnaltrexone 54 PROVENGE ® 54 primary hypercholesterolemia 54 Fatty liver 54 Aloprim TM allopurinol sodium 54 Genentech Rituxan 54 Phase 1a clinical 54 mixed dyslipidemia 54 Staphylococcus aureus Polysaccharide Conjugate 54 Biogen Genentech 54 Somatuline Depot 54 incyclinide 54 imetelstat GRN#L 54 gepirone ER 54 biliary tract cancer 54 Kit CD# positive 54 Pirfenidone 54 Phase 2a Clinical Trial 54 fostamatinib 54 intravenous methylnaltrexone 54 Quinamed 54 Lifeguard Collin Cobia 54 TASKi2 54 Ceragenin ™ 54 colorectal ovarian endometrial 54 BENICAR HCT 54 Company Nasdaq RGDX 54 Solzira ™ 54 neratinib 54 HIV maturation inhibition 54 diabetes pills Januvia 54 vaso occlusive crisis 54 Cabazitaxel 54 MAA submission 54 MEND CABG II 54 Zemiva TM Trofex TM 54 registrational trial 54 maximally tolerated dose 54 recombinant hepatitis B 54 Vaxfectin TM formulated 54 metastatic androgen independent 54 Bezielle 54 corticosteroid dexamethasone 54 Gonal f R 54 Xarelto rivaroxaban 54 Regeneron Pharma 54 ORACLE MS 54 AEG# 54 labial herpes 54 cancer neuroendocrine tumor 54 initiate multicenter Phase 54 Nicole Onetto MD 54 initiate Phase IIa 54 INCB# [001] 54 foot ulcers DFU 54 Roflumilast 54 HeFH 54 Phase Ib clinical trials 54 Alvine Pharmaceuticals Inc. 54 ORENCIA ® 54 JAK#/JAK# inhibitor CYT# 54 Surfaxin LS 54 OHR/AVR# 54 PLX MS 54 sitaxsentan 54 SYCREST 54 NASDAQ OREX 54 NFM celebrated 54 Hedgehog Pathway 54 Phase IIA 54 Tesmilifene 54 diabetic kidney 54 Novartis AG Galvus 54 GRNCM1 54 TÎ ² 4 54 Lu AA# 54 Zyflo CR 54 IV APAP 54 complement inhibitor eculizumab 54 placebo controlled multicenter 54 MUSE ® 54 ALVESCO HFA 54 occlusion PAO 54 Plaquenil 54 Eniluracil 54 Benlysta belimumab 54 ORENCIA R 54 rimonabant Acomplia 54 impaired glucose metabolism 54 commercial bioproduction 54 Prestara 54 sitagliptin Januvia 54 rheumatoid arthritis juvenile idiopathic 54 LUVENIQ 54 vaccine Synflorix 54 Phase III Clinical Trials 54 Laevo 54 TLK# 54 BiTE R 54 EmbraceAC 54 non splenectomized 54 JAK2 Inhibitor 54 granulated mesalamine 54 chemistry pharmacology toxicology 54 IMiDs 54 INOmax R 54 CEQ# 54 Myoblast 54 metabolism viral replication